Cytogenetical and hematological analysis of chronic myelogenous leukemia patients with a novel case 52XX, t (1;9;22) (q23.3; q34; q11.2), +6, +8, i(9) (q10;q10), +18,+19,+21+der22 t(9;22)(q34;q11)

(9;22) (q34; q11) translocation is appear in above ninety percent of chronic myelogenous leukemia patients while variant/complex translocations were observed in almost 5% to 8% chronic myelogenous leukemia (CML) positive cases. Gleevec (Imatinib Mesylate) is the first choice breakpoint cluster regio...

Descripción completa

Detalles Bibliográficos
Autores principales: Asif, Muhammad, Hussain, Abrar, Ali, Irfan, Baloch, Zarak, Rasool, Mahmood, Achakzai, Niaz M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666132/
https://www.ncbi.nlm.nih.gov/pubmed/36397339
http://dx.doi.org/10.1097/MD.0000000000031670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666132/
https://www.ncbi.nlm.nih.gov/pubmed/36397339
http://dx.doi.org/10.1097/MD.0000000000031670

Ejemplares similares